Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-31 @ 11:36 PM
Study NCT ID:
NCT07145450
Status:
RECRUITING
Last Update Posted:
2025-08-28
First Post:
2025-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Sponsor:
Anocca AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-03
Start Date Type:
ACTUAL
Primary Completion Date:
2030-04-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-09
First Submit QC Date:
None
Study First Post Date:
2025-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-20
Last Update Post Date:
2025-08-28
Last Update Post Date Type:
ESTIMATED